MiR-490-3p promotes cell apoptosis and cell-cycle arrest in osteosarcoma via the modulation of CDCA8/ATF3 by

Haoran Wang1, Hanqing Wang1, Zixiang Liu1

  • 1Department of Orthopedics, Hangzhou Children's Hospital, Hangzhou, China.

Translational Pediatrics
|January 17, 2025
PubMed
Abstract

Insights

Micro RNA-490-3p (miR-490-3p) upregulation inhibits osteosarcoma cell proliferation and metastasis by targeting NUSAP1. This microRNA promotes apoptosis and cell-cycle arrest, suggesting its potential as a therapeutic target for osteosarcoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Micro RNA-490-3p (miR-490-3p) is implicated in various cancers, but its specific role in osteosarcoma remains unclear.
  • Understanding the molecular mechanisms of miR-490-3p in osteosarcoma is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the role of miR-490-3p in osteosarcoma.
  • To elucidate the underlying molecular mechanism of miR-490-3p action in osteosarcoma cells.

Main Methods:

  • Real-time quantitative polymerase chain reaction (RT-qPCR) and western blot were used to assess gene and protein expression.
  • Cell Counting Kit-8 (CCK-8), wound-healing, and transwell assays evaluated cell proliferation, migration, and invasion.
  • Apoptosis, cell cycle, and target gene interactions were analyzed using TUNEL assays, flow cytometry, and luciferase reporter assays.

Main Results:

  • miR-490-3p expression was significantly reduced in osteosarcoma tissues.
  • Overexpression of miR-490-3p inhibited cell proliferation, migration, and invasion while promoting apoptosis and cell-cycle arrest.
  • miR-490-3p directly targets Nucleolar and Spindle-Associated Protein 1 (NUSAP1), regulating its expression and subsequently affecting CDCA8/ATF3 pathways.

Conclusions:

  • miR-490-3p suppresses osteosarcoma progression by inhibiting proliferation and metastasis through the NUSAP1/CDCA8/ATF3 axis.
  • Restoration of miR-490-3p levels presents a promising therapeutic strategy for osteosarcoma treatment.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.1K